TL;DR
This study investigates the role of heterozygous variants in the UNC13D gene in adult-onset Hemophagocytic Lymphohistiocytosis (HLH). They demonstrate that a specific UNC13D variant (c.2588G>A) can partially impair NK cell function, suggesting it acts as a genetic risk factor rather than a direct cause of HLH, especially when combined with other triggers.
What Problem Does This Paper Address?
Hemophagocytic Lymphohistiocytosis (HLH) is a severe, life-threatening hyperinflammatory condition. While primary (familial) HLH is typically caused by biallelic (two copies) mutations in specific genes, leading to recessive inheritance, there's growing evidence that heterozygous (one copy) variants in these genes might contribute to adult-onset HLH. However, the exact role and pathogenicity of these heterozygous variants, particularly in the UNC13D gene (critical for Natural Killer (NK) cell and cytotoxic T lymphocyte (CTL) function), remain unclear. This paper aims to clarify the impact of a specific heterozygous UNC13D variant (c.2588G>A) on NK cell cytotoxicity in the context of adult-onset HLH, especially when it occurs alongside other genetic variations.
Methods
The researchers employed a multi-pronged approach:
- Case Study: Detailed clinical presentation and diagnosis of a 29-year-old male patient with Epstein-Barr Virus (EBV)-triggered adult-onset HLH.
- Genetic Testing: Whole-exome sequencing (WES) was used to identify genetic variants in HLH-related genes in the patient and his family. Sanger sequencing was used for confirmation.
- NK Cell Function Assays:
- NK Cell Killing Assay: This assay measures the ability of NK cells to kill target cells. It was performed using flow cytometry to quantify early apoptotic and necrotic cells.
- CD107a Degranulation Assay: This assay assesses NK cell degranulation, a key step in their cytotoxic function, by measuring the expression of CD107a on the NK cell surface.
- Literature Review: A comprehensive review of 16 published studies was conducted to synthesize data on patients carrying the UNC13D c.2588G>A variant.
Datasets
- Patient and Family Pedigree Data: Genetic and functional data from the reported patient and his immediate family members (father, mother, sister, son).
- Literature Data: Data from 35 patients with the UNC13D c.2588G>A variant, compiled from 16 published studies.
Key Insights and Ideas
- Monoallelic UNC13D c.2588G>A Variant's Partial Impairment: The study strongly suggests that the heterozygous UNC13D c.2588G>A variant, unlike fully recessive variants, can partially impair NK cell cytotoxicity. This is a crucial distinction from the complete loss-of-function typically seen in familial HLH.
- Conditional Pathogenicity: The c.2588G>A variant appears to be "conditionally pathogenic." Its impact on NK cell function is not absolute but is likely exacerbated by other factors, such as viral infections (like EBV in this case), the presence of other genetic variants (like the compound heterozygous UNC13D c.1978_1979insATTACCG variant), or age-related immune decline.
- Genetic Risk Factor, Not Sole Cause: The findings position the heterozygous c.2588G>A variant as a potential genetic risk factor that predisposes individuals to conditions like HLH and lymphoma, rather than being the sole causative agent.
- MCM4/PIK3CD Variants Less Likely Contributors: While the patient also carried variants in MCM4 and PIK3CD, bioinformatic analysis and the mother's normal NK cell function suggested these were unlikely to be the primary drivers of the disease.
Key Results
- The patient, carrying compound heterozygous UNC13D variants (c.2588G>A and c.1978_1979insATTACCG), exhibited complete T/NK cytotoxicity dysfunction.
- NK cell killing activity in the patient was significantly reduced to 0.33% (normal ≥15.11%).
- Resting and activated CD107a expression, a marker for NK cell degranulation, was also significantly dropped in the patient.
- The patient's father, a heterozygous carrier of c.2588G>A, showed reduced NK cell cytotoxicity and lower CD107a expression compared to the mother.
- The mother, carrying the c.1978_1979insATTACCG variant, showed normal NK cell function, highlighting the distinct impact of the two UNC13D variants.
- A literature review identified 35 patients with the c.2588G>A variant, with HLH and lymphoma being the most common diagnoses.
Limitations and Future Work
- Limited Sample Size for Functional Assays: While the study provides valuable insights from a single patient and family, the functional impact of the UNC13D c.2588G>A variant needs to be verified in a larger cohort of healthy volunteers carrying this variant.
- Complexity of Interactions: The study acknowledges that NK cell cytotoxicity assays are influenced by multiple factors, and further research is needed to fully elucidate the complex interplay of genetic variants, viral infections, and immune function.
- In Silico Predictions: While bioinformatic tools were used to assess the pathogenicity of MCM4 and PIK3CD variants, these are predictions and require experimental validation.
- Future Directions: The authors suggest that larger cohort studies and more extensive functional assays are essential to definitively clarify the contribution of the UNC13D c.2588G>A variant to disease pathogenesis. They also emphasize the need for further investigation into the "conditionally pathogenic" nature of this variant.
Summary updated